SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding SpringWorks Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 137 | 149 | +12 |
| Shares | 66.5M | 66.3M | −192.2K (−0.3%) |
| Value | $1.73B | $1.70B | −$22.9M (−1.3%) |
New holders (25)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (13)
Institutions that held SpringWorks Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| PDT Partners, LLC | 50,387 | $1.31M |
| Allianz Asset Management GmbH | 24,500 | $637.2K |
| Samsara BioCapital, LLC | 22,204 | $577.5K |
| Quantbot Technologies LP | 16,700 | $434.4K |
| Y-Intercept (Hong Kong) Ltd | 16,344 | $425.1K |
| Axq Capital, LP | 15,214 | $395.7K |
| Sanders Morris Harris LLC | 11,200 | $291.3K |
| NinePointTwo Capital | 10,824 | $281.0K |
| Schonfeld Strategic Advisors LLC | 10,200 | $265.3K |
| SG Americas Securities, LLC | 5,403 | $141.0K |
| Virtus Investment Advisers, Inc. | 2,752 | $71.6K |
| High Net Worth Advisory Group LLC | 1,000 | $26.0K |
| GWM Advisors LLC | 18 | $468 |